Risarestat

Overview

Risarestat (CT-112), an aldose reductase inhibitor, is developed for the treatment of diabetic complications.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Aldose Reductase

Product Information

• Catalog No.: HY-16433
• CAS No.: 79714-31-1
• Molecular Formula: C16H21NO4S
• Molecular Weight: 323.41
• Purity: 98.03%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 5.25 mg/mL (16.23 mM); Clear solution
• Availability: In-stock

Source

Original product source